An analysis of FDA-approved drugs for psychiatric disorders

- A steady rate of approvals for psychiatric conditions has prevailed since the 1950s.
- The indications targeted vary over time with depression dominating current approvals.
- A subset of pathways, target types and means of prosecution dominates the field.